COMMUNIQUÉS West-GlobeNewswire

Mainz Biomed to Present Results of Pancreatic Cancer Verification Study at AACR 2026 Annual Meeting
14/01/2026
First data on blood-based mRNA signature for pancreatic ductal adenocarcinoma (PDAC) detection and intraductal papillary mucinous neoplasms (IPMN) differentiation to be presented in San Diego BERKELEY, Calif. and , Jan [...]
Senti Biosciences Participates in Virtual Investor CEO Connect Segment to Discuss the Company’s Groundbreaking AML Data at the American Society of Hematology Annual Meeting and Recently Granted RMAT Designation
14/01/2026
Access the segment here SOUTH SAN FRANCISCO, Calif., Jan. 14, 2026 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a clinical-stage biotechnology company developing next-generation cell and [...]
Acentra Health Appoints Deborah Ricci as Executive Vice President and Chief Financial Officer
14/01/2026
Accomplished financial executive brings over 35 years of experience in public and private sector MCLEAN, Va., Jan. 14, 2026 (GLOBE NEWSWIRE) -- Acentra Health , a technology and health solutions company dedicated to [...]
HealthTab™ to Expand Across North East London
14/01/2026
VANCOUVER, British Columbia, Jan. 14, 2026 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the " Company " or “ Avricore ”) today announced the planned expansion of its HealthTab™ platform across North East [...]
SoldierStrong Announces 2025 Recipients of Annual Individual Commitment to Service Award
14/01/2026
STAMFORD, Conn., Jan. 14, 2026 (GLOBE NEWSWIRE) -- SoldierStrong, the national nonprofit committed to delivering revolutionary medical technologies to America’s veterans, is proud to announce the individual co- [...]
Eagle Pharmaceuticals Announces Divestiture of Barhemsys
14/01/2026
WOODCLIFF LAKE, N.J., Jan. 14, 2026 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) is pleased to announce the divestiture of the marketing authorization for Barhemsys ( [...]
TellDx-Enabled Circulating Tumor Cell Analysis Predicts Response to DLL3-Targeted Therapy in Small Cell Lung Cancer
14/01/2026
-- Study Results Support the use of TellDx to Personalize Cancer Care Management – -- Clinical study published in Cancer Discovery -- ANDOVER, Mass., Jan. 14, 2026 (GLOBE NEWSWIRE) -- TellBio, Inc., a medical technology [...]
Affidea acquires a majority stake in LabPoint from Lindenhofgruppe, strengthening its diagnostics and laboratory medicine capabilities
14/01/2026
THE HAGUE, The Netherlands, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Affidea Group, Europe’s leading provider of advanced diagnostics, community-based polyclinics and specialised healthcare services including oncology, [...]
Affidea Suisse acquiert la participation majoritaire dans LabPoint cédée par le groupe Lindenhof, et renforce son offre de diagnostic et de médecine de laboratoire
14/01/2026
LE HAYE, Pays-Bas, 14 janv. 2026 (GLOBE NEWSWIRE) -- Le Groupe Affidea, l’un des principaux fournisseurs paneuropéens de services de santé spécialisés, notamment dans les domaines de la cancérologie, de l'imagerie [...]
AscellaHealth Launches Strategic Pharmacy Benefits Enablement Platform to Address 2026 Healthcare Cost and Access Challenges
14/01/2026
BERWYN, Pa., Jan. 14, 2026 (GLOBE NEWSWIRE) -- AscellaHealth , a global partner delivering customizable solutions for the specialty pharmaceutical industry, today announced the launch of AscellaOne™ , a technology- [...]
Cosmos Health Announces Initiation of Analyst Coverage with $4.50 Valuation by Zacks Small-Cap Research
14/01/2026
CHICAGO, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, today announced that Zacks Small-Cap [...]
Omniscient Secures New CPT® Code for Connectomic Analysis, Validating the Clinical Utility of Brain Network Mapping
14/01/2026
CHICAGO, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Omniscient (“o8t®”), a global pioneer in the use of AI to decode the human brain, today announced the issuance of a new Category III Current Procedural Terminology (CPT®) code [...]
Ultrahuman and Click Therapeutics partner to launch the world’s first biomarker-driven migraine management tool based on FDA-authorized technology
14/01/2026
Partnership brings the proprietary technology behind Click’s FDA-authorized digital migraine intervention to the Ultrahuman platform SAN FRANCISCO, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Ultrahuman, a global leader in [...]
Anresco NJ Labs Expands Nationwide Testing Network with New Bi-Coastal Laboratories for Amazon Readiness
14/01/2026
LOS ANGELES and MIDDLESEX, N.J., Jan. 14, 2026 (GLOBE NEWSWIRE) -- Anresco NJ Labs has expanded its laboratory network with aligned facilities on both the East and West Coasts, strengthening its ability to provide [...]
SOL Mental Health Celebrates Growth and Local Impact in 2025
14/01/2026
DENVER, Jan. 14, 2026 (GLOBE NEWSWIRE) -- SOL Mental Health, a leading provider of accessible outpatient mental and behavioral health services, celebrates highlights from 2025. Delivered outcomes-based integrated mental [...]
C4 Therapeutics Outlines Strategic Milestones to Advance Cemsidomide as a Potential Best-in-Class IKZF1/3 Degrader and Discovery Strategy Focused on Novel Targets in Clinically Validated Pathways
14/01/2026
Cemsidomide Phase 2 MOMENTUM Trial On Track to Initiate in Q1 2026; Recommended Phase 2 Dose is 100 µg Cemsidomide Phase 1b Trial in Combination With Elranatamab On Track to Initiate in Q2 2026 Internal Discovery [...]
NRx Pharmaceuticals (Nasdaq:NRXP) Announces 70,000 Patient Data on Real World Use of Ketamine for Treatment of Suicidal Depression to be Submitted to the FDA in Support of NRX-100 Approval
14/01/2026
NRX-100 (preservative-free ketamine) has been granted Fast Track Designation by FDA for treatment of suicidal ideation in patients with Depression and Bipolar Depression. Real-world evidence, consistent with FDA [...]
Glucose Health, Inc. Reports Debt-Free Balance Sheet and Previews New Soluble Fiber Brand
14/01/2026
BENTONVILLE, Ark., Jan. 14, 2026 (GLOBE NEWSWIRE) -- Glucose Health, Inc. (OTC: GLUC), a consumer-health company specializing in soluble-fiber nutrition products for metabolic support, today confirmed it has [...]
Emergent BioSolutions Receives U.S. FDA Approval on Supplemental New Drug Application for NARCAN® Nasal Spray to be Packaged in a New Carrying Case, Making Life-Saving Naloxone More Accessible for Everyday Preparedness
14/01/2026
Since the U.S. prescription launch of NARCAN® Nasal Spray in 2016, the medicine has been trusted as a safe, effective way to reverse opioid overdoses, and today, new solutions like the NARCAN® carrying case aims to make [...]

Pages